Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma
Felix Seelemeyer, David Pfister, Roberto Pappesch, et al.
European Urology Oncology (2023) Vol. 7, Iss. 3, pp. 319-322
Closed Access | Times Cited: 14

Showing 14 citing articles:

Biomarker microRNA-371a-3p - expression in malignancies other than germ-cell tumours
Gazanfer Belge, Markus Klemke, Bendix Hansen, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access
Diagnostic efficacy of serum microRNAs in predicting pathology of retroperitoneal lymph node dissection in patients with testicular germ cell tumors: a systematic review and meta-analysis
Mehdi Kardoust Parizi, Nirmish Singla, Siamak Daneshmand, et al.
World Journal of Urology (2025) Vol. 43, Iss. 1
Open Access
Hodentumor – welche Vorteile bringt der neue Tumormarker microRNA-371a-3p (M371-Test)
Klaus‐Peter Dieckmann, Gazanfer Belge
TumorDiagnostik & Therapie (2025) Vol. 46, Iss. 01, pp. 40-49
Closed Access
Retroperitoneal Lymph Node Dissection in Patients with Stage II Seminomatous Germ Cell Tumour
Christoph Oing, Pasquale Rescigno, Pia Paffenholz, et al.
European Urology Focus (2024) Vol. 10, Iss. 3, pp. 361-363
Closed Access | Times Cited: 2
Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node Dissection
Fady Baky, Nicole Liso, Brandon Williams, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 6, pp. 102217-102217
Closed Access | Times Cited: 1
Potential next generation markers of testicular germ cell tumors: miRNA-371a-3p
Zuci Shan, Xin Deng, Hongping Yang, et al.
International Urology and Nephrology (2024)
Closed Access | Times Cited: 1
Reply to Fumihiko Urabe, Takashi Yoshioka, and Takahiro Kimura’s Letter to the Editor re: Felix Seelemeyer, David Pfister, Robert Pappesch, Sabine Merkelbach-Bruse, Pia Paffenholz and Axel Heidenreich. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021
Felix Seelemeyer, David Pfister, Robert Pappesch, et al.
European Urology Oncology (2024) Vol. 7, Iss. 2, pp. 306-306
Closed Access
Regionalization of Testis Cancer Care—Is It Necessary?
Axel Heidenreich, Pia Paffenholz, David Pfister
Urologic Clinics of North America (2024) Vol. 51, Iss. 3, pp. 421-427
Closed Access
Seminom im klinischen Stadium IIA/B – machen oder nicht machen: welchen Stellenwert hat die retroperitoneale Lymphadenektomie?
Axel Heidenreich, Felix Seelemeyer, Ruben Gößmann, et al.
Aktuelle Urologie (2024)
Closed Access
Die primäre retroperitoneale Lymphadenektomie beim testikulären Keimzelltumor im klinischen Stadium IIA/B – Renaissance einer etablierten Therapie?
Julian Heidenreich, Ruben Gößmann, Felix Seelemeyer, et al.
Deleted Journal (2024)
Closed Access
Re: Felix Seelemeyer, David Pfister, Robert Pappesch, et al. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021
Fumihiko Urabe, Takashi Yoshioka, Takahiro Kimura
European Urology Oncology (2024) Vol. 7, Iss. 2, pp. 307-307
Closed Access
The relevance of circRNAs in serum of patients undergoing prostate biopsy
Fumihiko Urabe
International Journal of Urology (2024) Vol. 31, Iss. 5, pp. 581-581
Closed Access
Hodentumor – welche Vorteile bringt der neue Tumormarker microRNA-371a-3p (M371-Test)
Klaus‐Peter Dieckmann, Gazanfer Belge
Aktuelle Urologie (2024) Vol. 55, Iss. 06, pp. 510-519
Closed Access
Current Role of MicroRNAs in the Diagnosis and Clinical Management of Germ Cell Tumors
Nuno Tiago Tavares, Rui Henrique, Cármen Jerónimo, et al.
Surgical pathology clinics (2024) Vol. 18, Iss. 1, pp. 91-100
Closed Access
Page 1

Scroll to top